(Q71692742)
Statements
Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study (English)
D Perrault
E A Eisenhauer
K I Pritchard
L Panasci
B Norris
T Vandenberg